anthropic announced it will begin developing drugs directly through a new research platform, moving a language-model company into pharmaceutical development. this is a structural departure from prior ai-lab activity: model makers assisting research is common, but a lab declaring itself a drug developer blurs the line between tool-provider and product-owner in a heavily regulated industry.